1887

Abstract

Bovine papillomavirus type 1 is one of the aetiological agents of equine sarcoids. The viral major oncoprotein E5 is expressed in virtually all sarcoids, sarcoid cell lines and -transformed equine fibroblasts. To ascertain whether E5 behaves in equine cells as it does in bovine cells, we introduced the E5 open reading frame into fetal equine fibroblasts (EqPalF). As observed in primary bovine fibroblasts (BoPalF), E5 by itself could not immortalize EqPalF and an immortalizing gene, such as human telomerase (hTERT/hT), was required for the cells to survive selection. The EqPalF-hT-1E5 cells were morphologically transformed, elongated with many pseudopodia and capable of forming foci. Equine major histocompatibility complex class I (MHC I) was inhibited in these cells at least at two levels: transcription of MHC I heavy chain was inhibited and the MHC I complex was retained in the Golgi apparatus and prevented from reaching the cell surface. We conclude that, as in bovine cells and tumours, E5 is a player in the transformation of equine cells and the induction of sarcoids, and a potential major cause of MHC I downregulation and hence poor immune clearance of tumour cells.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.014746-0
2009-12-01
2019-11-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/90/12/2865.html?itemId=/content/journal/jgv/10.1099/vir.0.014746-0&mimeType=html&fmt=ahah

References

  1. Araibi, E. H., Marchetti, B., Ashrafi, G. H. & Campo, M. S. ( 2004; ). Down-regulation of MHC class I in bovine papillomas. J Gen Virol 85, 2809–2814.[CrossRef]
    [Google Scholar]
  2. Ashrafi, G. H., Tsirimonaki, E., Marchetti, B., O'Brien, P. M., Sibbet, G. J., Andrew, L. & Campo, M. S. ( 2002; ). Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins. Oncogene 21, 248–259.[CrossRef]
    [Google Scholar]
  3. Ashrafi, G. H., Piuko, K., Burden, F., Yuan, Z., Gault, E. A., Muller, M., Trawford, A., Reid, S. W. J., Nasir, L. & Campo, M. S. ( 2008; ). Vaccination of sarcoid-bearing donkeys with chimeric virus-like particles of bovine papillomavirus type 1. J Gen Virol 89, 148–157.[CrossRef]
    [Google Scholar]
  4. Borzacchiello, G., Russo, V., Della Salda, L., Roperto, S. & Roperto, F. ( 2008; ). Expression of platelet-derived growth factor-beta receptor and bovine papillomavirus E5 and E7 oncoproteins in equine sarcoids. J Comp Pathol 139, 231–237.[CrossRef]
    [Google Scholar]
  5. Brandt, S., Haralambus, R., Shafti-Keramat, S., Steinborn, R., Stanek, C. & Kirnbauer, R. ( 2008; ). A subset of equine sarcoids harbours BPV-1 DNA in a complex with L1 major capsid protein. Virology 375, 433–441.[CrossRef]
    [Google Scholar]
  6. Chambers, G., Ellsmore, V. A., O'Brien, P. M., Reid, S. W. J., Love, S., Campo, M. S. & Nasir, L. ( 2003; ). Sequence variants of bovine papillomavirus E5 detected in equine sarcoids. Virus Res 96, 141–145.[CrossRef]
    [Google Scholar]
  7. Ellis, S. A., Martin, A. J., Holmes, E. C. & Morrison, W. I. ( 1995; ). At least four MHC class I genes are transcribed in the horse: phylogenetic analysis suggests an unusual evolutionary history for the MHC in this species. Eur J Immunogenet 22, 249–260.[CrossRef]
    [Google Scholar]
  8. Grindlay, G. J., Campo, M. S. & O'Brien, V. ( 2005; ). Transactivation of the cyclin A promoter by bovine papillomavirus type 4 E5 protein. Virus Res 108, 29–38.[CrossRef]
    [Google Scholar]
  9. Hallamaa, R. E., Saario, E. & Tallberg, T. ( 2005; ). Macroscopical and histopathological changes in regressing primary and recurrent equine sarcoids during active specific bio-immunotherapy. In Vivo 19, 761–767.
    [Google Scholar]
  10. Knottenbelt, D. C. ( 2005; ). A suggested clinical classification of the equine sarcoid. Clinical Techniques in Equine Practice 4, 278–295.[CrossRef]
    [Google Scholar]
  11. Marchetti, B., Ashrafi, G. H., Tsirimonaki, E., O'Brien, P. M. & Campo, M. S. ( 2002; ). The papillomavirus oncoprotein E5 retains the major histocompatibility class I in the Golgi apparatus and prevents its transport to the cell surface. Oncogene 21, 7808–7816.[CrossRef]
    [Google Scholar]
  12. Marchetti, B., Ashrafi, G. H., Araibi, E. H., Ellis, S. A. & Campo, M. S. ( 2006; ). The E5 protein of BPV-4 interacts with the heavy chain of MHC class I and irreversibly retains the MHC complex in the Golgi apparatus. Oncogene 25, 2254–2263.[CrossRef]
    [Google Scholar]
  13. Mattil-Fritz, S., Scharner, D., Piuko, K., Thones, N., Gissmann, L., Muller, H. & Muller, M. ( 2008; ). Immunotherapy of equine sarcoid: dose-escalation trial for the use of chimeric papillomavirus-like particles. J Gen Virol 89, 138–147.[CrossRef]
    [Google Scholar]
  14. Nasir, L. & Campo, M. S. ( 2008; ). Bovine papillomaviruses: their role in the aetiology of cutaneous tumours of bovids and equids. Vet Dermatol 19, 243–254.[CrossRef]
    [Google Scholar]
  15. Nasir, L., Gault, E., Morgan, I. M., Chambers, G., Ellsmore, V. & Campo, M. S. ( 2007; ). Identification and functional analysis of sequence variants in the long control region and the E2 open reading frame of bovine papillomavirus type 1 isolated from equine sarcoids. Virology 364, 355–361.[CrossRef]
    [Google Scholar]
  16. O'Brien, V., Ashrafi, G. H., Grindlay, G. J., Anderson, R. & Campo, M. S. ( 1999; ). A mutational analysis of the transforming functions of the E8 protein of bovine papillomavirus type 4. Virology 255, 385–394.[CrossRef]
    [Google Scholar]
  17. Pennie, W. D., Grindlay, G. J., Cairney, M. & Campo, M. S. ( 1993; ). Analysis of the transforming functions of bovine papillomavirus type 4. Virology 193, 614–620.[CrossRef]
    [Google Scholar]
  18. Suprynowicz, F. A., Campo, M. S. & Schlegel, R. ( 2006; ). Biological activities of papillomavirus E5 proteins. In Papillomavirus Research: From Natural History To Vaccines and Beyond, pp. 97–113. Edited by M. S. Campo. Norwich, UK: Caister Academic Press.
  19. Tsirimonaki, E., Ullah, R., Marchetti, B., Ashrafi, G. H., McGarry, L., Ozanne, B. & Campo, M. S. ( 2006; ). Similarities and differences between the E5 oncoproteins of bovine papillomaviruses type 1 and type 4: cytoskeleton, motility and invasiveness in E5-transformed bovine and mouse cells. Virus Res 115, 158–168.[CrossRef]
    [Google Scholar]
  20. Yuan, Z., Gallagher, A., Gault, E. A., Campo, M. S. & Nasir, L. ( 2007; ). Bovine papillomavirus infection in equine sarcoids and in bovine bladder cancers. Vet J 174, 599–604.[CrossRef]
    [Google Scholar]
  21. Yuan, Z. Q., Gault, E. A., Gobeil, P., Nixon, C., Campo, M. S. & Nasir, L. ( 2008a; ). Establishment and characterization of equine fibroblast cell lines transformed in vivo and in vitro by BPV-1: model systems for equine sarcoids. Virology 373, 352–361.[CrossRef]
    [Google Scholar]
  22. Yuan, Z. Q., Nicolson, L., Marchetti, B., Gault, E. A., Campo, M. S. & Nasir, L. ( 2008b; ). Transcriptional changes induced by bovine papillomavirus type 1 in equine fibroblasts. J Virol 82, 6481–6491.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.014746-0
Loading
/content/journal/jgv/10.1099/vir.0.014746-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error